TipRanks
Go Ultimate55% OFF

Compare CARsgen Therapeutics Holdings Ltd. (CRTHF) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CRTHFCARsgen Therapeutics Holdings Ltd.$1.62$805.12M-56.08167.77%Moderate SellUnlock the CRTHF analyst price target with TipRanks PremiumCRTHFUnlock the CRTHF top-analyst price target with TipRanks Premium
HK:9688Zai Lab LtdHKD 17.37HKD 21.69B-12.70-14.77%Strong BuyUnlock the HK:9688 analyst price target with TipRanks PremiumCRTHF vs HK:9688Unlock the HK:9688 top-analyst price target with TipRanks Premium
HK:9966Alphamab OncologyHKD 6.22HKD 6.06B-30.68-45.77%―Unlock the HK:9966 analyst price target with TipRanks PremiumCRTHF vs HK:9966Unlock the HK:9966 top-analyst price target with TipRanks Premium
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class HHKD 15.26HKD 30.07B-69.15-39.11%Moderate BuyUnlock the HK:1877 analyst price target with TipRanks PremiumCRTHF vs HK:1877Unlock the HK:1877 top-analyst price target with TipRanks Premium
HK:2126JW (Cayman) Therapeutics Co. Ltd.HKD 2.22HKD 925.48M-2.35-35.65%―Unlock the HK:2126 analyst price target with TipRanks PremiumCRTHF vs HK:2126Unlock the HK:2126 top-analyst price target with TipRanks Premium
HK:2616CStone PharmaceuticalsHKD 4.94HKD 7.77B-15.53-20.45%Moderate BuyUnlock the HK:2616 analyst price target with TipRanks PremiumCRTHF vs HK:2616Unlock the HK:2616 top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CRTHFCARsgen Therapeutics Holdings Ltd.1.621.02167.77%
HK:9688Zai Lab Ltd17.37-3.65-17.36%
HK:9966Alphamab Oncology6.21-5.46-46.79%
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class H15.26-11.44-42.85%
HK:2126JW (Cayman) Therapeutics Co. Ltd.2.22-1.82-45.05%
HK:2616CStone Pharmaceuticals4.94-1.28-20.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts